

Struggling to find Ceftriaxone in stock? Here are practical tools and tips to locate this injectable antibiotic at pharmacies and clinics near you in 2026.
If your doctor has prescribed Ceftriaxone and you've been told it's out of stock, you're dealing with a frustrating reality that thousands of patients face every week. Ceftriaxone — a critical injectable antibiotic used for infections ranging from pneumonia to meningitis — has been in an active shortage since 2023.
But "in shortage" doesn't mean "impossible to find." Ceftriaxone is still being manufactured and distributed. The challenge is figuring out where it's available right now. In this guide, we'll walk you through practical tools and tips to track it down.
The fastest way to find Ceftriaxone in stock is to use Medfinder. Instead of calling pharmacy after pharmacy, Medfinder lets you search for medication availability across a network of pharmacies, hospitals, and clinics near your location.
Here's how it works:
This saves you time, reduces the number of phone calls, and helps you find the medication before supply runs out at a given location. For a step-by-step walkthrough, see our guide on how to check if a pharmacy has Ceftriaxone in stock.
When a drug is in shortage, large chain pharmacies (CVS, Walgreens, Rite Aid) often run out first because they serve the highest volume of patients and may face allocation limits from wholesalers. Independent pharmacies, on the other hand, may use different distributors or have smaller but more flexible supply chains.
Here's what to look for:
Don't assume a pharmacy doesn't have it just because the big chains are out. Make a few extra calls — it can make all the difference.
Drug shortages aren't constant — supply comes in waves. Here are some timing strategies that can help:
If you can't find Ceftriaxone after exhausting these options, your doctor can prescribe an alternative antibiotic. Depending on the type of infection you're treating, alternatives may include:
For a deeper dive on your options, read our post on alternatives to Ceftriaxone.
If you've tried everything and still can't find Ceftriaxone, here are a few more options:
Hospital pharmacies sometimes have stock that isn't available through outpatient channels. Your doctor or their staff can call the hospital pharmacy directly to check availability and potentially arrange for your treatment to be administered there.
Your insurance company may be able to help locate pharmacies in their network that have Ceftriaxone in stock. Some plans have dedicated shortage assistance lines or can authorize treatment at a facility that has supply, even if it's out of your usual network.
Organizations like NeedyMeds (needymeds.org) can connect you with resources and programs that may help you access medications during shortages, especially if cost is also a concern.
Shortage severity varies by region. If you're in a rural area or a region that's been hit particularly hard, a pharmacy or clinic in a neighboring city may have stock. Medfinder can help you expand your search radius to find the nearest available supply.
Finding Ceftriaxone during a shortage takes persistence, but it is possible. Start with Medfinder to see real-time availability, branch out to independent and specialty pharmacies, and time your search for early in the week when new stock arrives.
If the shortage is delaying your treatment, talk to your doctor about alternatives to Ceftriaxone — there are effective options for most infections. And for more on why this shortage is happening in the first place, read our post on why Ceftriaxone is so hard to find.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.